AUSTIN, Texas– On May 9, 2022, Capital Factory will launch its new Center for Health Innovation at Pegasus Park in Dallas to spur momentum for health and life sciences innovation in Texas. This launch event will begin with a Dallas Startup Crawl on Monday evening and be followed on May 10 with Health Supernova, presented by UT Dallas and UT Southwestern Medical Center — the premier event to engage with the most promising health and biotech startups in Texas.
“The rapid pace of change in the health sector makes it difficult to keep tabs on what new technology is available — and viable — and where to invest. Capital Factory is one of the most active health tech investors in Texas, and we’ve been building our portfolio of biotech investments for a few years,” said Capital Factory CEO Joshua Baer. “By partnering with Pegasus Park, we are excited to see that portfolio continue to gain momentum while helping connect the Pegasus Park community to our unmatched innovation partners in Austin, Houston, and San Antonio.”
With notable partners like McKesson, Blue Cross and Blue Shield of Texas’ C1 Innovation Lab, and Amazon Web Services (AWS), this inaugural event features a host of impressive speakers, such as Dr. William (Billy) Cohn from Johnson & Johnson, Dr. Claire Aldridge from Taysha Gene Therapies, and Dr. Amy Kruse of Prime Movers Lab. In addition, Health Supernova will include a Biotech+ Innovation Showcase during which five Capital Factory healthcare startups will showcase to an audience of healthcare professionals, investors, and entrepreneurs.
“The Center for Health Innovation has the potential to improve health and create new industries in North Texas by bringing together key stakeholders in healthcare and connecting them to innovators with cutting-edge solutions,” said Dr. Claire Aldridge, SVP, Chief of Staff and Business Operations at Taysha Gene Therapies. “Capital Factory’s experience in bridging these groups will further accelerate our potential to lead regionally, nationally, and — ultimately — globally in improving patient outcomes and health economics.”
